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CC BY-NC-ND license.Cardiovascular diseases (CVD), principally ischemic
heart disease and stroke, remain the leading cause of
mortality worldwide and a major contributor to disability
and rising healthcare costs [1e4]. In 2010 alone, CVD was
a primary cause of 15.6 million global deaths [1] and an
estimated US$863 billion in direct healthcare costs and
productivity losses worldwide [5]. In fact, these costs are
projected to reach US$20 trillion by the year 2030 [5]. In
spite of this huge toll on global health and development,
reports from the Institute of Medicine, the World Heart
Federation, and the World Health Organization state that
CVD is rarely on the global health agenda and is not highly
prioritized by policy makers, development aid agencies,
and leading foundations, especially in reference to health in
low- and middle-income countries (LMIC) [6e9].
An important ﬁrst step in tackling this global CVD
epidemic is to determine the magnitude of the disease and
risk factor burden at the regional and local population levels
and to inform strategies for CVD and CVD risk factor pre-
vention, treatment, and control [8,9]. Publication of theGBD
(Global Burden of Diseases, Injuries, and Risk Factors) 2010
study ﬁndings in 2012 provided a consistent and compa-
rable methodology for assessing disease burden from 235
causes of death (including 9 CVD causes) for 20 age groups
in 1990 and 2010 [1,2,10]. Since that time, the GBD 2010
Cardiovascular Diseases Expert Groups have published the
methodology for systematic reviews and epidemiological
estimates of disease incidence, prevalence, case fatality, as
well as mortality and disability-adjusted life years (DALY)
for several CVD causes of disease burden [11e18]. In this
issue of Global Heart, we extend this work by presenting
together in one issue additional details and analyses on
ischemic heart disease (IHD) [19], hemorrhagic stroke [20],
ischemic stroke [21], atrial ﬁbrillation [22], myocarditis
[23], infective endocarditis [24], abdominal aortic aneurysm
[25,26], and peripheral arterial disease [27].
For IHD, Moran et al. [19] demonstrate that in 2010,
nearly two-thirds of global IHD DALY occurred in middle-
income countries. In the North Africa/Middle East and
South Asia regions, the mean age at onset of IHD events was
<50 years old in more than 29% of male and 24% of female
subjects. Although age-standardized IHDDALYdecreased in
most countries between 1990 and 2010, they increased in
the Eastern Europe/Central Asia and South Asia regions.
Importantly, age-standardized DALY varied substantially by
country within regions, especially among middle-income
countries. This variation in IHD DALY was highest—up to
8-fold—in middle-income countries, and was lowest in
high-income countries.GLOBAL HEART, VOL. 9, NO. 1, 2014
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rhagic stroke and showed a 47% increase in the absolute
number of cases worldwide from 1990 to 2010. The LMIC
contributed 80% of incident cases, 63% of deaths, and 86%
of DALY lost. The highest rates of incident hemorrhagic
stroke were seen in LMIC regions, especially in Sub-Saharan
Africa and East Asia, whereas the lowest rates occurred in
High-Income North America andWestern Europe [20]. The
ﬁndings for ischemic stroke in LMICwere just as ominous as
those for hemorrhagic stroke [21]. Overall, the LMIC
contributed 63% of incident cases, 57% of deaths, and 64%
of DALY lost worldwide. Tobacco use was an important risk
factor for ischemic stroke, and China, Russia, and India
ranked highest in both 1990 and 2010 for ischemic stroke
deaths attributable to tobacco consumption [21].
Chugh et al. [22] explored the differences in atrial
ﬁbrillation burden between developing and developed
countries and showed that overall, the burden of atrial
ﬁbrillation is greater in the high-income countries; however,
the mortality associated with atrial ﬁbrillation in women is
higher in LMIC. Sampson et al. [27] also showed that the
global burden of lower extremity peripheral arterial disease
has increased over the last 20 years, especially among
women, and that the disease is increasingly being seen in
younger age groups. Additionally, the increases in peripheral
arterial disease burden in LMIC exceed the increases in
developed countries [27]. In contrast, global prevalence,
incidence, and mortality rates for abdominal aortic aneu-
rysm have decreased consistently over the last 20 years [26].
However, these global trends mask important regional
trends as seen in the Asia Paciﬁc High-Income region where
mortality for abdominal aortic aneurysm rose signiﬁcantly
and was largely driven by rising rates in women [26]. The
substantial degree of heterogeneity within regions highlights
the need for investing in and improving regional as well as
country- and local-level CVD surveillance.
Cooper et al. [23] and Abdulhak et al. [24] provide the
systematic review ﬁndings for myocarditis and infective
endocarditis, respectively, as a basis for future global burden
of disease assessments. In particular, they highlight the sig-
niﬁcant lack of ideal population-based epidemiological data
in LMIC for these conditions.
The series of articles presented in this issue of Global
Heart provides an important focus on the magnitude and
trends in the global burden of CVD over the last 20 years.
The ﬁndings presented here can help inform clinical and
public health strategies for the prevention, treatment, and
control of CVD. However, they also highlight substantial
heterogeneity of ﬁndings within regions, highlighting the183
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tional and local levels to better tailor intervention strategies
to the local disease burden and trends. These articles
conﬁrm that there is a disproportionate and rising burden
of CVD in LMIC; that the burden is particularly prominent
in MIC; and that CVD are increasingly affecting younger
age groups. These patterns reﬂect highly complex in-
teractions between development, demographic change, and
disparities in exposures to risk factors and access to high-
quality health care. These articles also provide further
support for the current global call for CVD and other
chronic noncommunicable diseases to be considered
important developmental challenges ripe for inclusion in
the post-2015 global health agenda [28].
REFERENCES
1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality
from 235 causes of death for 20 age groups in 1990 and 2010: a
systematic analysis for the Global Burden of Disease Study 2010.
Lancet 2012;380:2095–128.
2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs)
for 291 diseases and injuries in 21 regions, 1990e2010: a systematic
analysis for the Global Burden of Disease Study 2010. Lancet 2012;
380:2197–223.
3. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A Race Against
Time: The Challenge of Cardiovascular Disease in Developing Coun-
tries. New York, NY: Trustees of Columbia University, 2004.
4. Tarride JE, Lim M, DesMeules M, et al. A review of the cost of car-
diovascular disease. Can J Cardiol 2009;25:e195–202.
5. Bloom DE, Caﬁero ET, Jane-Llopis E, et al. The Global Economic
Burden of Noncommunicable Diseases. Geneva, Switzerland: World
Economic Forum, 2013.
6. Institute of Medicine. Promoting Cardiovascular Health in the
Developing World: A Critical Challenge To Achieve Global Health.
Washington, DC: National Academies Press, 2010.
7. Fuster V, Voute J, Hunn M, Smith SC Jr. Low priority of cardiovas-
cular and chronic diseases on the global health agenda: a cause for
concern. Circulation 2007;116:1966–70.
8. Fuster V, Voute J. MDGs: chronic diseases are not on the agenda.
Lancet 2005;366:1512–4.
9. World Health Organization. Neglected global epidemics: three growing
threats. In: TheWorld Health Report, 2003: Shaping the Future. Geneva,
Switzerland: WHO; 2003:83–102.
10. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of
burden of disease and injury attributable to 67 risk factors and risk
factor clusters in 21 regions, 1990e2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet 2012;380:2224–60.
11. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology
of atrial ﬁbrillation: a Global Burden of Disease 2010 study. Circula-
tion 2013 Dec 17 [E-pub ahead of print].
12. Mensah GA, Foroufanzar MH, Naghavi M, et al. Comparable esti-
mates of mortality and trends for cardiovascular diseases including
congenital heart disease in 21 world regions in 1990 and 2010: theGlobal Burden of Diseases, Injuries and Risk Factors (GBD 2010
Study). J Am Coll Cardiol 2013;61:E1406.
13. Mensah GA. Descriptive epidemiology of cardiovascular risk factors
and diabetes in Sub-Saharan Africa. Prog Cardiovasc Dis 2013;56:
240–50.
14. Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G.
The epidemiology of cardiovascular diseases in Sub-Saharan Africa:
the Global Burden of Diseases, Injuries and Risk Factors 2010 study.
Prog Cardiovasc Dis 2013;56:234–9.
15. Moran AE, Oliver JT, Mirzaie M, et al. Assessing the global burden of
ischemic heart disease: part 1: methods for a systematic review of
the global epidemiology of ischemic heart disease in 1990 and 2010.
Glob Heart 2012;7:315–29.
16. Wilkinson JD, Zebrowski JP, Hunter JA, et al. Assessing the global and
regional impact of primary cardiomyopathies: the Global Burden of
Diseases, Injuries and Risk Factors (GBD 2010). Study. Prog Car-
diovasc Dis 2011;32:55–63.
17. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and
regional burden of ﬁrst-ever ischaemic and haemorrhagic stroke
during 1990e2010: ﬁndings from the Global Burden of Disease Study
2010. Lancet Global Health 2013;1:e259–81.
18. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. for the GBD 2010
Investigators and GBD Stroke Experts Group. Global and regional
burden of stroke during 1990e2010: ﬁndings from the Global Burden
of Disease Study 2010. Lancet 2013;383:245–54.
19. Moran AE, Tzong KY, Forouzanfar MH, et al. Variations in ischemic
heart disease burden by age, country, and income: the Global Burden
of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart 2014;9:
91–9.
20. Krishnamurthi R, Moran AE, Foroufanzar MH, et al. The global burden
of hemorrhagic stroke: a summary of ﬁndings from the GBD 2010
study. Glob Heart 2014;9:101–6.
21. Bennett DA, Krishnamurthi RV, Barker-Collo S, et al. The global
burden of ischemic stroke: ﬁndings of the GBD 2010 study. Glob
Heart 2014;9:107–12.
22. Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial
ﬁbrillation in developed and developing nations. Glob Heart 2014;9:
113–9.
23. Cooper LT Jr, Keren A, Sliwa K, Matsumori A, Mensah GA. The global
burden of myocarditis. Part 1: a systematic literature review for the
Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob
Heart 2014;9:121–9.
24. Bin Abdulhak AA, Baddour LM, Erwin PJ, et al. Global and regional
burden of infective endocarditis, 1990e2010: a systematic review of
the literature. Glob Heart 2014;9:131–43.
25. Sampson UKA, Norman PE, Fowkes FGR, et al. Estimation of global
and regional incidence and prevalence of abdominal aortic aneu-
rysms 1990 to 2010. Glob Heart 2014;9:159–70.
26. Sampson UKA, Norman PE, Fowkes FGR, et al. Global and regional
burden of aortic dissection and aneurysms: mortality trends in 21
world regions, 1990 to 2010. Glob Heart 2014;9:171–80.
27. Sampson UKA, Fowkes FGR, McDermott MM, et al. Global and
regional burden of death and disability from peripheral artery dis-
ease: 21 world regions, 1990 to 2010. Glob Heart 2014;9:145–58.
28. Alleyne G, Binagwaho A, Haines A, et al. for the Lancet NCD Action
Group. Embedding non-communicable diseases in the post-2015
development agenda. Lancet 2013;381:566–74.GLOBAL HEART, VOL. 9, NO. 1, 2014
March 2014: 183-184
